Connection

PETER HOTEZ to Hookworm Infections

This is a "connection" page, showing publications PETER HOTEZ has written about Hookworm Infections.
Connection Strength

13.210
  1. A Journey in Science: Molecular vaccines for global child health in troubled times of anti-science. Mol Med. 2024 Mar 15; 30(1):37.
    View in: PubMed
    Score: 0.782
  2. Vaccine value profile for Hookworm. Vaccine. 2024 07 25; 42(19 Suppl 1):S25-S41.
    View in: PubMed
    Score: 0.760
  3. The yin and yang of human soil-transmitted helminth infections. Int J Parasitol. 2021 12; 51(13-14):1243-1253.
    View in: PubMed
    Score: 0.665
  4. Empowering Girls and Women through Hookworm Prevention. Am J Trop Med Hyg. 2018 05; 98(5):1211-1212.
    View in: PubMed
    Score: 0.510
  5. Advancing a vaccine to prevent hookworm disease and anemia. Vaccine. 2016 06 03; 34(26):3001-3005.
    View in: PubMed
    Score: 0.450
  6. Worm Infections in Children. Pediatr Rev. 2015 Aug; 36(8):341-52; quiz 353-4.
    View in: PubMed
    Score: 0.430
  7. In reply. Obstet Gynecol. 2014 Jun; 123(6):1354.
    View in: PubMed
    Score: 0.397
  8. Advancing a multivalent 'Pan-anthelmintic' vaccine against soil-transmitted nematode infections. Expert Rev Vaccines. 2014 Mar; 13(3):321-31.
    View in: PubMed
    Score: 0.386
  9. Helminth infections: a new global women's health agenda. Obstet Gynecol. 2014 Jan; 123(1):155-160.
    View in: PubMed
    Score: 0.386
  10. The Human Hookworm Vaccine. Vaccine. 2013 Apr 18; 31 Suppl 2:B227-32.
    View in: PubMed
    Score: 0.367
  11. Vaccinomics for the major blood feeding helminths of humans. OMICS. 2011 Sep; 15(9):567-77.
    View in: PubMed
    Score: 0.323
  12. Developing vaccines to combat hookworm infection and intestinal schistosomiasis. Nat Rev Microbiol. 2010 Nov; 8(11):814-26.
    View in: PubMed
    Score: 0.310
  13. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev Vaccines. 2008 Aug; 7(6):745-52.
    View in: PubMed
    Score: 0.265
  14. Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults. Vaccine. 2008 May 02; 26(19):2408-17.
    View in: PubMed
    Score: 0.258
  15. Hookworm vaccines. Clin Infect Dis. 2008 Jan 15; 46(2):282-8.
    View in: PubMed
    Score: 0.255
  16. Use of the air pouch model to investigate immune responses to a hookworm vaccine containing the Na-ASP-2 protein in rats. Parasite Immunol. 2008 Jan; 30(1):53-6.
    View in: PubMed
    Score: 0.254
  17. Hookworm and poverty. Ann N Y Acad Sci. 2008; 1136:38-44.
    View in: PubMed
    Score: 0.251
  18. Hookworm vaccines: past, present, and future. Lancet Infect Dis. 2006 Nov; 6(11):733-41.
    View in: PubMed
    Score: 0.235
  19. New technologies for the control of human hookworm infection. Trends Parasitol. 2006 Jul; 22(7):327-31.
    View in: PubMed
    Score: 0.227
  20. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006 May 06; 367(9521):1521-32.
    View in: PubMed
    Score: 0.227
  21. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med. 2005 Oct; 2(10):e295.
    View in: PubMed
    Score: 0.218
  22. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J. 2005 Oct; 19(12):1743-5.
    View in: PubMed
    Score: 0.215
  23. Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum. Vaccine. 2005 May 02; 23(24):3123-30.
    View in: PubMed
    Score: 0.211
  24. Hookworm: "the great infection of mankind". PLoS Med. 2005 Mar; 2(3):e67.
    View in: PubMed
    Score: 0.210
  25. Hookworm infection. N Engl J Med. 2004 Aug 19; 351(8):799-807.
    View in: PubMed
    Score: 0.201
  26. Human hookworm infection in the 21st century. Adv Parasitol. 2004; 58:197-288.
    View in: PubMed
    Score: 0.193
  27. Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative. Int J Parasitol. 2003 Sep 30; 33(11):1245-58.
    View in: PubMed
    Score: 0.189
  28. Investigation of urinary metabolomics in a phase I hookworm vaccine trial in Gabon. PLoS One. 2022; 17(9):e0275013.
    View in: PubMed
    Score: 0.177
  29. Safety and immunogenicity of the Na-APR-1 hookworm vaccine in infection-na?ve adults. Vaccine. 2022 10 06; 40(42):6084-6092.
    View in: PubMed
    Score: 0.176
  30. Characterization of T cell responses to co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in healthy adults in Gabon. PLoS Negl Trop Dis. 2021 10; 15(10):e0009732.
    View in: PubMed
    Score: 0.165
  31. Maternal Hookworm Infection and Its Effects on Maternal Health: A Systematic Review and Meta-Analysis. Am J Trop Med Hyg. 2020 11; 103(5):1958-1968.
    View in: PubMed
    Score: 0.155
  32. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial. Lancet Infect Dis. 2021 02; 21(2):275-285.
    View in: PubMed
    Score: 0.153
  33. Experimental approaches to the development of a recombinant hookworm vaccine. Immunol Rev. 1999 Oct; 171:163-71.
    View in: PubMed
    Score: 0.144
  34. Epidemiology of hookworm infection in Itagua, Paraguay: a cross sectional study. Mem Inst Oswaldo Cruz. 1999 Sep-Oct; 94(5):583-6.
    View in: PubMed
    Score: 0.143
  35. Ancylostoma secreted protein 1 (ASP-1) homologues in human hookworms. Mol Biochem Parasitol. 1999 Jan 05; 98(1):143-9.
    View in: PubMed
    Score: 0.136
  36. Epidemiology of human intestinal nematode infections in Wujiang and Pizhou counties, Jiangsu Province, China. Southeast Asian J Trop Med Public Health. 1998 Sep; 29(3):605-10.
    View in: PubMed
    Score: 0.133
  37. A novel blood-feeding detoxification pathway in Nippostrongylus brasiliensis L3 reveals a potential checkpoint for arresting hookworm development. PLoS Pathog. 2018 03; 14(3):e1006931.
    View in: PubMed
    Score: 0.129
  38. Vaccines for hookworm infection. Pediatr Infect Dis J. 1997 Oct; 16(10):935-40.
    View in: PubMed
    Score: 0.125
  39. Safety and immunogenicity of the Na-GST-1 hookworm vaccine in Brazilian and American adults. PLoS Negl Trop Dis. 2017 05; 11(5):e0005574.
    View in: PubMed
    Score: 0.121
  40. Advances in neglected tropical disease vaccines: Developing relative potency and functional assays for the Na-GST-1/Alhydrogel hookworm vaccine. PLoS Negl Trop Dis. 2017 02; 11(2):e0005385.
    View in: PubMed
    Score: 0.120
  41. Hookworm infection. Nat Rev Dis Primers. 2016 12 08; 2:16088.
    View in: PubMed
    Score: 0.118
  42. The Global Economic and Health Burden of Human Hookworm Infection. PLoS Negl Trop Dis. 2016 09; 10(9):e0004922.
    View in: PubMed
    Score: 0.116
  43. Human anthelminthic vaccines: Rationale and challenges. Vaccine. 2016 06 24; 34(30):3549-55.
    View in: PubMed
    Score: 0.113
  44. Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting. Vaccine. 2016 Apr 27; 34(19):2197-206.
    View in: PubMed
    Score: 0.112
  45. New Vaccines for the World's Poorest People. Annu Rev Med. 2016; 67:405-17.
    View in: PubMed
    Score: 0.108
  46. Molecular pathobiology of hookworm infection. Infect Agents Dis. 1995 Jun; 4(2):71-5.
    View in: PubMed
    Score: 0.106
  47. New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74. Hum Vaccin Immunother. 2015; 11(5):1251-7.
    View in: PubMed
    Score: 0.103
  48. The medical biochemistry of poverty and neglect. Mol Med. 2014 Dec 16; 20 Suppl 1:S31-6.
    View in: PubMed
    Score: 0.103
  49. Optimization and revision of the production process of the Necator americanus glutathione S-transferase 1 (Na-GST-1), the lead hookworm vaccine recombinant protein candidate. Hum Vaccin Immunother. 2014; 10(7):1914-25.
    View in: PubMed
    Score: 0.096
  50. Molecular mechanisms of hookworm disease: stealth, virulence, and vaccines. J Allergy Clin Immunol. 2012 Jul; 130(1):13-21.
    View in: PubMed
    Score: 0.087
  51. Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies. Hum Vaccin Immunother. 2012 Jun; 8(6):765-76.
    View in: PubMed
    Score: 0.086
  52. Potency testing for the experimental Na-GST-1 hookworm vaccine. Expert Rev Vaccines. 2010 Oct; 9(10):1219-30.
    View in: PubMed
    Score: 0.077
  53. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis. J Infect Dis. 2010 May 15; 201(10):1561-9.
    View in: PubMed
    Score: 0.075
  54. A plan to defeat neglected tropical diseases. Sci Am. 2010 Jan; 302(1):90-4, 96.
    View in: PubMed
    Score: 0.073
  55. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J. 2009 Sep; 23(9):3007-19.
    View in: PubMed
    Score: 0.070
  56. Modelling heterogeneity and the impact of chemotherapy and vaccination against human hookworm. J R Soc Interface. 2008 Nov 06; 5(28):1329-41.
    View in: PubMed
    Score: 0.067
  57. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl Trop Dis. 2008 Sep 24; 2(9):e300.
    View in: PubMed
    Score: 0.067
  58. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl Trop Dis. 2008 Sep 17; 2(9):e291.
    View in: PubMed
    Score: 0.067
  59. A Global Fund to Fight Neglected Tropical Diseases: is the G8 Hokkaido Toyako 2008 Summit ready? PLoS Negl Trop Dis. 2008 Mar 26; 2(3):e220.
    View in: PubMed
    Score: 0.065
  60. A new voice for the poor. PLoS Negl Trop Dis. 2007 Oct 31; 1(1):e77.
    View in: PubMed
    Score: 0.063
  61. Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. Clin Vaccine Immunol. 2007 Mar; 14(3):281-7.
    View in: PubMed
    Score: 0.060
  62. The co-distribution of Plasmodium falciparum and hookworm among African schoolchildren. Malar J. 2006 Nov 03; 5:99.
    View in: PubMed
    Score: 0.059
  63. Vaccines against blood-feeding nematodes of humans and livestock. Parasitology. 2006; 133 Suppl:S63-79.
    View in: PubMed
    Score: 0.055
  64. Immunogenicity of the hookworm Na-ASP-2 vaccine candidate: characterization of humoral and cellular responses after vaccination in the Sprague Dawley rat. Hum Vaccin. 2005 May-Jun; 1(3):123-8.
    View in: PubMed
    Score: 0.053
  65. Helminth infections of children: prospects for control. Adv Exp Med Biol. 2005; 568:135-44.
    View in: PubMed
    Score: 0.052
  66. Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial. Lancet Infect Dis. 2024 Jul; 24(7):760-774.
    View in: PubMed
    Score: 0.049
  67. Human Intestinal Parasite Burden and Poor Sanitation in Rural Alabama. Am J Trop Med Hyg. 2017 Nov; 97(5):1623-1628.
    View in: PubMed
    Score: 0.031
  68. Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol. 2006 Sep; 36(10-11):1143-51.
    View in: PubMed
    Score: 0.014
  69. Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop Med Int Health. 2006 Jan; 11(1):56-64.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.